1. Home
  2. XENE vs FORM Comparison

XENE vs FORM Comparison

Compare XENE & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • FORM
  • Stock Information
  • Founded
  • XENE 1996
  • FORM 1993
  • Country
  • XENE Canada
  • FORM United States
  • Employees
  • XENE N/A
  • FORM N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • FORM Semiconductors
  • Sector
  • XENE Health Care
  • FORM Technology
  • Exchange
  • XENE Nasdaq
  • FORM Nasdaq
  • Market Cap
  • XENE 2.3B
  • FORM 2.2B
  • IPO Year
  • XENE 2014
  • FORM N/A
  • Fundamental
  • Price
  • XENE $32.05
  • FORM $32.55
  • Analyst Decision
  • XENE Strong Buy
  • FORM Buy
  • Analyst Count
  • XENE 11
  • FORM 7
  • Target Price
  • XENE $54.82
  • FORM $41.17
  • AVG Volume (30 Days)
  • XENE 977.8K
  • FORM 648.2K
  • Earning Date
  • XENE 08-07-2025
  • FORM 07-30-2025
  • Dividend Yield
  • XENE N/A
  • FORM N/A
  • EPS Growth
  • XENE N/A
  • FORM N/A
  • EPS
  • XENE N/A
  • FORM 0.69
  • Revenue
  • XENE $7,500,000.00
  • FORM $766,230,000.00
  • Revenue This Year
  • XENE N/A
  • FORM $2.18
  • Revenue Next Year
  • XENE $253.71
  • FORM $7.14
  • P/E Ratio
  • XENE N/A
  • FORM $47.06
  • Revenue Growth
  • XENE N/A
  • FORM 15.33
  • 52 Week Low
  • XENE $26.74
  • FORM $22.58
  • 52 Week High
  • XENE $46.00
  • FORM $63.63
  • Technical
  • Relative Strength Index (RSI)
  • XENE 51.34
  • FORM 50.93
  • Support Level
  • XENE $31.22
  • FORM $33.35
  • Resistance Level
  • XENE $33.46
  • FORM $35.02
  • Average True Range (ATR)
  • XENE 1.28
  • FORM 1.22
  • MACD
  • XENE 0.27
  • FORM -0.09
  • Stochastic Oscillator
  • XENE 68.60
  • FORM 48.05

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Share on Social Networks: